Pakistan Tightens Safety Surveillance For Devices
New pharmacovigilance guidance covers medical devices too
A new guidance document explains how Pakistan’s revamped therapeutic product surveillance system will work.
You may also be interested in...
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.
Vifor Pharma has resubmitted a marketing application for avacopan to the European Medicines Agency – this time for an unconditional approval.